An evolving ecosystem with over 80 Greek startupswho are active in the field medical sciences and from life sciences, began to appear in Greece. This was also reflected in studies carried out BSE to register the needs, as well as the problems of a particular market, on the margin and its 1st Health and Life Sciences Meeting held in July at the office of the Association.

According to the study, Greece is dominated by digital healthcare companies, with new technologies being discovered in the areas of bioinformatics and medical equipment and device development. Less represented, however, are Greek biotech companies, a sector that raised $47 billion last year in America alone. According to a BSE survey, 8 out of 10 companies (45 sector participants) are considering reaching out to large companies in other countries, as well as attracting investments , as the most important factors in their development, while 70% consider it necessary to facilitate the conduct of clinical trials and access to programs such as NSRP. At the same time, more than half are interested in cooperation with hospitals and primary health care departments, and 6 out of 10 also consider access to large databases necessary, a service that has not yet matured enough in our country.

As pointed out by “K” Lambros Curtis, general manager of The Sanguine Lab and one of the committee members, the goal was to capture the needs of companies in order to explore actions and proposals that would advance the life sciences. sector in GREECE. The second meeting, which will take place in October, will focus on digital health, taking into account the interest of companies in this sector, with the participation of market representatives from Greece and other countries. Among the concerns of companies are support for start-ups to protect industrial property, support for technology transfer from research groups to companies, and a significant boost to the development of the entire sector will provide incentives to attract investment from multinational corporations in Greece, as well as tax incentives in the first five years.